• June 3-6, 2024
  • San Diego Convention Center, California

Sessions

Loading

FibroBiologics Clinical Update

Monday, June 03, 2024
CP
Regenerative Medicine
Based in Houston, FibroBiologics is a cell therapy, regenerative medicine company developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. FibroBiologics holds 150+ US and internationally issued patents/patents pending across various clinical pathways, including disc degeneration, orthopedics, multiple sclerosis, psoriasis, wound healing, reversing organ involution, and cancer. FibroBiologics represents the next generation of medical advancement in cell therapy.
FibroBiologics Clinical Update
Company Website: http://www.fibrobiologics.com
Lead Product in Development: Multiple Sclerosis and Wound Care
Number Of Unlicensed Products (For Which You Are Seeking Partners): 6

Exchange

Nasdaq Global Exchange

Ticker

FBLG

Company HQ City

Houston

Company HQ State

Texas

Company HQ Country

United States

CEO/Top Company Official

Pete OHeeron

Development Phase of Primary Product

Phase I
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS